The United States Supreme Court held in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. et al. (No. 17-1229, 2019) that inventor’s sale of an invention to a third party who is obligated to keep the invention confidential can qualify as prior art under section 102(a) of title 35 of the United States Code. The…
Donika Pentcheva is pleased to announce that her research involving intellectual property law has been cited in In RE: Industrial Print Technologies, LLC, Patent Litigation, a case pending before the Northern District of Texas. Before the Court were seven identical Motions for Leave to Amend the Pleadings to Add Acacia Research Group, LLC (“ARG”) as…
Beginning June 16, 2020, the Director of the United States Patent and Trademark Office (“USPTO”) will accept petitions to advance initial examination of applications for marks used to identify qualifying COVID-19 medical products and services. Because the USPTO considers the effects of COVID-19 to be an “extraordinary situation” within the meaning of 37 C.F.R. §…